Fulltext:
283283.pdf
Embargo:
until further notice
Size:
1.258Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2022Source
Pharmaceutical Statistics, 21, 5, (2022), pp. 879-894ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Health Evidence
Journal title
Pharmaceutical Statistics
Volume
vol. 21
Issue
iss. 5
Page start
p. 879
Page end
p. 894
Subject
Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience; Health Evidence - Radboud University Medical CenterAbstract
In early phase clinical studies in oncology, Simon's two-stage designs are widely used. The trial design could be made more efficient by stopping early in the second stage when the required number of responses is reached, or when it has become clear that this target can no longer be met (a form of non-stochastic curtailment). Early stopping, however, will affect proper estimation of the response rate. We propose a uniformly minimum-variance unbiased estimator (UMVUE) for the response rate in this setting. The estimator is proven to be UMVUE using the Rao-Blackwell theorem. We evaluate the estimator's properties in terms of bias and mean squared error, both analytically and via simulations. We derive confidence intervals based on sample space orderings, and assess the coverage. For various design options, we evaluate the reduction in expected sample size as a function of the true response rate. Our method provides a solution for estimating response rates in case of a non-stochastic curtailment Simon's two-stage design.
This item appears in the following Collection(s)
- Academic publications [244228]
- Electronic publications [131195]
- Faculty of Medical Sciences [92893]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.